Jeff Gold
Venture Partner, Longitude Capital
Jeff Gold focuses on investments in medical devices. Prior to Longitude, Mr. Gold was Chief Executive Officer of CryoVascular Systems, a medical device company developing treatments for peripheral vascular disease, from 2001 to 2005. CryoVascular was acquired by Boston Scientific Corporation in 2005. Between 1997 and 2000, Mr. Gold was COO and Executive Vice President of CardioThoracic Systems (NASDAQ: CTSI), a medical device company focused on developing products to enable off-pump open-heart surgery. CTSI completed an IPO in 1996 and was subsequently acquired by Guidant Corporation. Prior to CTSI, Mr. Gold spent 18 years with Cordis Corporation, the primary cardiovascular device subsidiary of Johnson & Johnson. He currently serves on the Boards of Access Closure, AngioDynamics (NASDAQ: ANGO), Niagara Gorge Medical Devices, Velomedix and Voyage Medical. He also is a member of the Executive Committee of the Center for Entrepreneurship & Innovation at the University of Florida. Mr. Gold holds an M.B.A. from the University of Florida and a B.S. in Engineering from Northeastern University, and is a graduate of GE's Manufacturing Management Program.

Frank F. Rahmani
Partner, Cooley Godward Kronish LLP
Mr. Rahmani is a partner in the Cooley Godward Kronish Business department and head of the firm's Medical Device Companies practice group. Resident in the Palo Alto office, he has been with the Firm since 1997. Mr. Rahmani has a general business and corporate law practice with an emphasis in the representation of emerging growth companies, intellectual property transactions, securities transactions, including private and public financing, and mergers and acquisitions. Mr. Rahmani has counseled companies, entrepreneurs and investors in a broad range of matters including start-up formation and spin-off transactions, assistance with obtaining early stage financing, technology acquisition and licensing matters, to later stage financings, strategic and commercial relationships, variety of public offerings and mergers and acquisitions. Mr. Rahmani counsels companies in a wide range of industries including medical devices and life sciences, software, semiconductor and telecommunication equipment. Mr. Rahmani received a J.D., from Santa Clara University School of Law in 1997, where he was on the Deans' List and was a representative to the American Bar Association. He received a business degree from Santa Clara University. Prior to joining Cooley, Mr. Rahmani was an analyst with Intel Corporation working with the corporate finance and worldwide sales organizations. Mr. Rahmani is a member of the State Bar of California.

Jason Yip
Principal, Montgomery & Co.
Mr. Yip has over 10 years of M&A, financing and advisory experience in medical devices and HCIT. He has significant strategic advisory experience, including sale of Proprius Pharmaceuticals, HealthHero Network, and Vivant Medical, as well as selected strategic assignments for Amgen, Edwards Lifesciences, NMT Medical, Orthovita and Urologix. Mr. Yip has a broad range of public and private financing experience, including IPOs for Bioform Medical, Power Medical Interventions and Accuray, follow-on offerings and PIPEs for Spectranetics and Inverness Medical, and private placements for Power Medical Interventions and Pathway Medical. Prior to joining Montgomery, Mr. Yip was an investment banker at Jefferies, focused on the medical technology sector. He began his career as a management consultant to emerging and established healthcare, medical device, and HCIT companies at Fletcher Spaght. Mr. Yip received an MBA from The Wharton School at the University of Pennsylvania. He also received a Master of Engineering and a Bachelor of Science in biomedical engineering and electrical engineering from MIT.